DE69326008D1 - 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren - Google Patents

17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren

Info

Publication number
DE69326008D1
DE69326008D1 DE69326008T DE69326008T DE69326008D1 DE 69326008 D1 DE69326008 D1 DE 69326008D1 DE 69326008 T DE69326008 T DE 69326008T DE 69326008 T DE69326008 T DE 69326008T DE 69326008 D1 DE69326008 D1 DE 69326008D1
Authority
DE
Germany
Prior art keywords
pct
image
alpha
reductase inhibitors
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69326008T
Other languages
English (en)
Other versions
DE69326008T2 (de
Inventor
Bruce Witzel
Jeffrey Bergman
Richard Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69326008D1 publication Critical patent/DE69326008D1/de
Application granted granted Critical
Publication of DE69326008T2 publication Critical patent/DE69326008T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69326008T 1992-05-20 1993-05-17 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren Expired - Fee Related DE69326008T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88605792A 1992-05-20 1992-05-20
PCT/US1993/004633 WO1993023038A1 (en) 1992-05-20 1993-05-17 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS

Publications (2)

Publication Number Publication Date
DE69326008D1 true DE69326008D1 (de) 1999-09-16
DE69326008T2 DE69326008T2 (de) 2000-03-02

Family

ID=25388288

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326008T Expired - Fee Related DE69326008T2 (de) 1992-05-20 1993-05-17 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren

Country Status (8)

Country Link
US (1) US5639741A (de)
EP (1) EP0649431B1 (de)
JP (1) JPH07508034A (de)
AT (1) ATE183193T1 (de)
AU (1) AU675225B2 (de)
CA (1) CA2135057A1 (de)
DE (1) DE69326008T2 (de)
WO (1) WO1993023038A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329149T2 (de) * 1992-05-20 2001-03-29 Merck & Co Inc 4-azasteroide als 5-alpha-reduktase
CA2158345A1 (en) * 1993-03-15 1994-09-29 Marvin L. Bayne Cloned human alpha 1c adrenergic receptor
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5817818A (en) * 1994-09-16 1998-10-06 Glaxo Wellcome Inc. Androstenones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
US7009052B2 (en) * 2003-03-20 2006-03-07 Warner Lambert Company Llc Sulfonamide derivatives
EP1620459A4 (de) * 2003-05-07 2007-06-06 Cedars Sinai Medical Center Intrazelluläres östradiol bindendes protein, polynukleotid, das für dieses codiert, und zellinien, die dieses überexprimieren
WO2004100874A2 (en) * 2003-05-07 2004-11-25 Merck & Co., Inc. Androgen receptor modulators and methods of use thereof
AU2004259664B2 (en) * 2003-06-30 2009-05-28 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
JP2007521292A (ja) * 2003-06-30 2007-08-02 メルク エンド カムパニー インコーポレーテッド アンドロゲン受容体モジュレータとしての17−アセトアミド−4−アザステロイド誘導体
AU2004256075B2 (en) * 2003-06-30 2008-12-04 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
FR2858216B1 (fr) * 2003-07-31 2008-04-04 Oreal Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
US20050169863A1 (en) * 2003-07-31 2005-08-04 L'oreal 2-Thioacetamide compositions for stimulating the growth of keratin fibers and/or for reducing loss thereof
JP6300436B2 (ja) * 2012-09-18 2018-03-28 株式会社山田養蜂場本社 テストステロン−5α−リダクターゼ阻害剤

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227876A (en) * 1937-10-16 1941-01-07 Firm Of N V Organon Steroid derivatives with nuclear substituted nitrogen
US3285918A (en) * 1962-04-18 1966-11-15 Norman J Doorenbos 1', 4', 5', 6'-tetrahydropyrimidino[a-4, 3]-4-aza-5-cholestene
US3239417A (en) * 1962-12-07 1966-03-08 Smith Kline French Lab Methods and compositions for inhibiting sterol biosynthesis
US3264301A (en) * 1963-08-22 1966-08-02 Norman J Doorenbos Substituted-4-azasteroids
FR1465544A (fr) * 1965-11-29 1967-01-13 Roussel Uclaf Dérivés stéroïdes aromatiques substitués par un atome d'azote endocyclique et procédé de préparation
CA970692A (en) * 1971-11-08 1975-07-08 Walter Voigt METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
EP0314199B1 (de) * 1984-02-27 1991-09-18 Merck & Co. Inc. 17-Beta-substituierte-4-aza-5-alpha-Androstenone und ihre Anwendung als 5-Alpha-Reduktase-Inhibitoren
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
US5110939A (en) * 1987-01-28 1992-05-05 Smithkline Beecham Corporation Intermediates in the preparation of steriod 5-alpha-reductase inhibitors
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5116983A (en) * 1988-04-18 1992-05-26 Merck & Co., Inc. Dehydrogenation process intermediates
JP2675418B2 (ja) * 1988-05-25 1997-11-12 スミスクライン・ベックマン・コーポレイション 芳香族ステロイド5‐α‐レダクターゼ抑制剤
US4882319A (en) * 1988-12-23 1989-11-21 Smithkline Beckman Corporation Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4970205A (en) * 1988-12-23 1990-11-13 Smithkline Beecham Corporation Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
GB9002922D0 (en) * 1990-02-09 1990-04-04 Erba Carlo Spa 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
WO1993023420A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
RU2141967C1 (ru) * 1992-05-21 1999-11-27 Андорешерш Инк. ИНГИБИТОРЫ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИНГИБИРОВАНИЯ АКТИВНОСТИ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ
AU5695594A (en) * 1992-12-10 1994-07-04 Poli Industria Chimica S.P.A. Thio- and oxo-azasteroids, processes for the preparation thereof, use thereof as antiandrogens and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0649431A4 (en) 1995-05-03
ATE183193T1 (de) 1999-08-15
US5639741A (en) 1997-06-17
EP0649431B1 (de) 1999-08-11
EP0649431A1 (de) 1995-04-26
AU4250693A (en) 1993-12-13
DE69326008T2 (de) 2000-03-02
WO1993023038A1 (en) 1993-11-25
AU675225B2 (en) 1997-01-30
CA2135057A1 (en) 1993-11-25
JPH07508034A (ja) 1995-09-07

Similar Documents

Publication Publication Date Title
ATE195129T1 (de) 4-azasteroide als 5-alpha-reduktase
ATE183193T1 (de) 17-amino-substituierte 4-azasteroide als 5-alpha- reductase inhibitoren
CA2173863A1 (en) 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
KR960704555A (ko) 5-알파 환원효소 억제제를 사용한 안드로겐성 탄모증의 치료 방법(Method of treating androgenic alopecia with 5-alpha reductase inhibitors)
ATE143942T1 (de) Carbonsäurederivate als 5-alpha-reduktase- inhibitor
ATE178795T1 (de) 7-substituierte-4-aza-steroid-derivate als 5- alpha-reductase-hemmer
ATE198274T1 (de) 17 beta-aryl-4-aza-steroidderivate
DE69615046T2 (de) 17-alkyl-7-substituierte-4-aza-steroidderivate
NO20000469L (no) Legemiddel for skallethet og andre sykdommer
HU9501935D0 (en) Indole derivatives as steroid 5-alpha-reductase inhibitors
ES2099007A1 (es) Derivados de indol.
YU12295A (sh) 16-supstituisani-4-aza-androstani inhibitori 5-alfa-reduktaze izozima 1

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee